GI remains solid investment option | Blood test for 50 cancers | Pros/cons of large GI groups | Medicare payments - is it rigged against physicians?
Praveen Suthrum
Cofounder, NextServices | Author, The Shift, Scope Forward | GI Mastermind
Gastroenterology remains 'solid, steady' investment option (Becker's GI & Endoscopy)
Gastroenterology and urology remain steady investment opportunities in 2022, according to an Aug. 14 article in JDSupra from the law firm Bass, Berry & Sims.
ACG Legislative & Public Policy Council Chair Dr. Louis Wilson discusses Medicare cuts & possible changes to the Medicare Economic Index, affecting pts & GI practices.
As PE becomes an even more compelling capital partner for practices, the Advisory Board team answers some of the biggest unanswered questions.
The review explores trends in malpractice facing gastroenterologists and offers strategies to deliver high-quality and safe patient care.
Experts share 15 pieces of best practice advice for managing NAFLD in lean individuals, who are at increased risk of cardiovascular, liver and all-cause mortality.
Anne Marie Lennon, MD, PhD, FASGE, discusses how to attract and retain GIs as the specialty faces ongoing physician shortages.
The benefits, drawbacks of gastroenterologists joining large groups: 1 CEO's perspective (Becker's GI & Endoscopy)
Jerry Tillinger, CEO of U.S. Digestive Health, spoke with Becker's to discuss what larger organizations have to offer GIs.
Geneoscopy Inc announced completed enrollment of the CRC-PREVENT pivotal trial for its noninvasive, at-home diagnostic screening test.
Phage combination therapy can precisely target IBD-related gut bacteria without harming helpful microbes (Microbiome Times)
Scientists have designed a phage combination therapy that can precisely target and suppress gut bacteria associated with IBD.
领英推荐
Gastric emptying tests may be used for assessing patients with symptoms, but is it time to discard these tests? Find out with Dr. Peter Buch and Dr. Reena Chokshi .
Discovering ERCP with Peter B. Cotton, MD?(Gut Talk)
Peter B. Cotton, MD, professor of medicine at the Medical University of South Carolina, discusses the development and invention of the ERCP procedure, the innovation of digestive disease centers and more.
The Galleri blood test can detect up to 50 different cancers from a single blood draw, but there is concern among clinicians that widespread clinical use of the test may be premature.
Doctors pioneer non-invasive 'string test' for sedation-free upper gastrointestinal monitoring?(Medical Xpress)
The EnteroTracker can monitor EoE and may have uses in detecting other diseases including GERD, EGE, FAE, and?IBD.
Gut health is the key to healing a lot of diseases, says Sunny Jain, founder of Sun Genomics, a San Diego-based health startup that makes customized probiotics for customers.
Digbi Health and Novo Nordisk pilot testing Genetic and Gut Microbiome-based Digital Solutions (PR Newswire)
Digbi Health, is enrolled in Novo Nordisk's Global Prevention Accelerator Program, to pilot-test solutions for the prevention of obesity and related conditions.
Comparison of Colonoscopy, Fecal Immunochemical Test, and Risk-adapted Approach in a CRC Screening Trial (CGH Journal)
Directing people to either stool tests or colonoscopies based on their risk factors offers a viable alternative to screening for CRC.
In a multinational study led by a Mayo Clinic research team using artificial intelligence (AI), investigators developed an algorithm to improve the prediction of colorectal cancer recurrence.
Barrett’s Neoplasia Often Missed (GI & Endoscopy News)
“Just like colon lesions can be missed after colonoscopy, Barrett’s neoplasia can be missed after upper endoscopy. We know that these cancers and neoplasias are being missed at the index endoscopy,” Prateek Sharma, MD quoted.